S0003629

Nevirapine 200mg tabs/PAC-60


Nevirapine 200 mg tablets, bottle or blister pack of 60
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Nevirapine 200mg tablets, pack of 60

Technical Specifications:
Each tablet contains Nevirapine 200mg calculated on the anhydrous basis.

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
36 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral), PO.
Prevention of mother-to-child transmission in HIV-infected patients

Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack
May be taken with or without regard to food

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items
Related Products